By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Vectura Limited 

1 Prospect West

Chippenham    SN14 6FH  United Kingdom
Phone: 44-0-1249-667700 Fax: 44-0-1249-667701


SEARCH JOBS


Industry
Pharmaceutical






Company News
Mundipharma AG Signs New Deal With Vectura Limited For Global Development And Commercialization Of Inhaled Triple Therapy VR2076 For The Treatment Of Asthma And COPD 12/27/2016 9:16:59 AM
Vectura Limited Pays A Whopping $181 Million For Activaero 3/13/2014 8:18:01 AM
Vectura Limited Gets $7.5 Million as Novartis Corporation (NVS) Starts Key Trial 5/10/2010 11:43:53 AM
Vectura Limited and Sandoz Pharmaceuticals Revise VR315 Agreement; Vectura to Receive $9.5 Million Payment and up to $25 Million Loan Facility 3/18/2010 11:42:12 AM
GlaxoSmithKline (GSK) Up as Novartis Corporation (NVS) Drops Generic Advair in U.S.; Novartis Hands Back U.S. Rights to VR315 to Vectura Limited 3/18/2010 7:03:21 AM
Vectura Limited Revenue Up, Key Drugs to Start Phase III 5/19/2009 7:26:39 AM
Arakis Ltd. And Vectura Group PLC Announce Agreement On New Therapy For Respiratory Disease10/19/2005 5:13:16 PM
Novartis Pharma AG (NVS) In UK Biotech Deal Worth Up To $375 Milllon10/19/2005 5:13:16 PM
SkyePharma Inc. (SKYE) And Vectura Limited Form Strategic Alliance For Pulmonary Delivery Technologies10/19/2005 5:11:35 PM
Vectura, Evolutec File To Try IPO Luck On London Market10/19/2005 5:08:46 PM
12
//-->